ALB and COVID-19: We detected antibodies against the SARS-CoV-2 spike protein in the CSF of 22.6–44.1% of the patients, which positively correlated with serum antibody levels, peripheral leucocyte counts, increasing Q-Alb and COVID-19 severity.